Meeting
2022 ASCO Annual Meeting
A digital imaging analysis (DIA) platform for identifying tertiary lymphoid structures (TLS) in lung adenocarcinoma (LUAD).
Authors
Vladimir Kushnarev
BostonGene Corporation, Waltham, MA
Vladimir Kushnarev , Anna Belozerova , Daniil Dymov , Yuriy Popov , Nadezhda Lukashevich , Ivan Valiev , Diana Shamsutdinova , Aida Akaeva , Ilia Galkin , Lev Popyvanov , Viktor Svekolkin , Krystle Nomie , Anna Love , Alexander Bagaev , Ekaterina Postovalova , Nathan Fowler
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Tissue-Based Biomarkers
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 3142)
DOI
10.1200/JCO.2022.40.16_suppl.3142
Abstract #
3142
Poster Bd #
134
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Effect of combination of genomic variation–based machine learning and clinical pathology on accurate diagnosis of tumors: Lung adenocarcinoma and lung squamous cell carcinoma.
First Author: Weiguang Gu
Poster
2023 ASCO Breakthrough
Heterogeneity of PD-L1 expression among resected EGFR-mutated NSCLC and prognostic implications.
First Author: Stephanie Pei Li Saw
Poster
2022 ASCO Annual Meeting
![[<sup>18</sup>F]Fluorothymidine(FLT)-PET imaging of thymidine kinase 1 pharmacodynamics in non-small cell lung cancer treated with pemetrexed.](https://d201v5jt9ylckg.cloudfront.net/288/14358/210839/210839_A1308_poster_pv.jpg)
[18F]Fluorothymidine(FLT)-PET imaging of thymidine kinase 1 pharmacodynamics in non-small cell lung cancer treated with pemetrexed.
First Author: Preetha Aravind
Poster
2022 ASCO Annual Meeting
Artificial intelligence in digital pathology approach identifies the predictive impact of tertiary lymphoid structures with immune-checkpoints therapy in NSCLC.
First Author: Mehrdad Rakaee